Drmitsui Medical Haemorrhoid Gel
NDC Package 87267-011-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Drmitsui Medical Haemorrhoid (phenylephrine hci witch hazel) gel is swith an appropriate cleansing wipe.Gently dry by patting or blotting witha tissue or a soft cloth before applyinggel. This formulation utilizes a gel delivery system. Marketed by Yiyangyuan Life Sciences (hong Kong) Co., Limited, this product is identified by NDC 87267-011 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
87267-011-01
Package Description
5 TUBE in 1 BOX / 5 g in 1 TUBE
Product Code
11-Digit Billing Format
87267001101
RxNorm Crosswalk
  • RxCUI: 249465 - phenylephrine HCl 0.25 % / witch hazel 50 % Rectal Gel
  • RxCUI: 249465 - phenylephrine 0.0025 MG/MG / witch hazel 0.5 MG/MG Rectal Gel
  • RxCUI: 249465 - phenylephrine 0.25 % / witch hazel 50 % Rectal Gel

Clinical Specifications

Proprietary Name
Drmitsui Medical Haemorrhoid
Non-Proprietary Name
Phenylephrine Hci Witch Hazel
Substance Name
Phenylephrine Hydrochloride; Witch Hazel
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
Swith an appropriate cleansing wipe.Gently dry by patting or blotting witha tissue or a soft cloth before applyinggel. When first opening the tube,puncture foil seal with topend of cap..Apply externally to the affectedarea up to 4 times daily, especiallyat night, in the morning or aftereach bowel movement..Childrenunder 12 years of age: ask a doctor.

Regulatory & Marketing

Labeler Name
Yiyangyuan Life Sciences (hong Kong) Co., Limited
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-10-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87267-011-01 identifies a specific commercial package of 5 tube in 1 box / 5 g in 1 tube of Drmitsui Medical Haemorrhoid, a human over the counter drug labeled by Yiyangyuan Life Sciences (hong Kong) Co., Limited. This gel is formulated for topical use and contains phenylephrine hydrochloride; witch hazel as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Yiyangyuan Life Sciences (hong Kong) Co., Limited on May 10, 2026. The current certification is valid through December 31, 2027.

How is this Yiyangyuan Life Sciences (hong Kong) Co., Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87267001101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87267-011-01
11-Digit CMS (5-4-2)
87267-0011-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.